PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Pharma-Bio Serv, Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026
- Market cap
- $11.00M
- P/E (TTM)
- 48.0
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
-1712.0%
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | $1.72M | -1712.0% |
| FY2024 | – | – | $1.72M | -221.5% |
| FY2023 | – | – | $1.72M | 131.6% |
| FY2022 | – | – | $3.45M | 342.4% |
| FY2021 | – | – | $1.73M | -82.7% |
| FY2020 | – | – | $1.73M | 84.1% |
| FY2019 | $0.07 | – | $0 | 0.0% |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.